News

Sign on now… Approved in the US, France, Canada and South Africa. Public discussion banned by NHS England… access blocked in UK

Dozens of studies from CROI 2016: PrEP, new HIV drugs, paediatric and access… plus STOP-PRESS news that NHS England blocks PrEP in the UK…

First reports from CROI in Boston: dozens of studies and an overview of other issues…

Access to care in the UK, generic dolutegravir at $44 per year, new US and WHO guidelines, PrEP submited for EU approval…

This manual contains eight modules with questions and answers. This manual is designed for people with no previous knowledge of the subjects. Read the manual online – please check dates for each section. The current online web pages for sections 1 to …

Generic versions of newly recommended antiretrovirals and fixed dose combination (FDC) regimens will be available for adults this year and next. But for children key formulations to implement 2013 recommendations are still unavailable.   Among the many announcements and outpourings …

i-Base will run a reduced treatment information service between Christmas and the New Year. If you have an urgent enquiry during this period, please contact your clinic. The phoneline will be closed between 23rd December and 4th January. We will …

On 16 December 2015, Channel 4 news include a short story about PrEP. Watch on YouTube. The report included interviews with activists from i-Base and the community PrEP organisations I Want PrEP Now and Prepster. We hope this raises the …

News and reports to challenge HIV treatment and prevention strategies for 2016… EACS 2015, access, guidelines, PrEP

Lower dose efavirenz (EFV), dolutegravir (DTG) and tenofovir alafenamide fumarate (TAF) are expected to make up a large chunk of the adult first-line market over the next five years, and contribute to treatment cost reductions, according to rrecent projections by …

For more than two decades, AEGiS was the largest and most comprehensive online HIV library.  It was also one of the first organisations to prioritise open-access to resources on HIV and AIDS.  Unfortunately, increasing difficulty with sustaining funding meant that this …

< Pocket pregnancy guide is a small i-Base leaflet about HIV and pregnancy. It includes information about planning your pregnancy, using ART, delivery and after care including feeding. This includes a focus on the importance of the mothers’ health and how this …

This blog is a from a 5-minute open mic talk last night held downstairs at KuKlub bar in Soho. I hadn’t planned to speak until I got to the bar, but wanted to link four current stories about HIV, HCV, …

Note: at CROI 2017, a higher risk of viral rebound and development of integrase inhibitor drug resistance means that dolutegravir monotherapy is not recommended. Anyone using dolutegravir is recommended to switch to dual or triple therapy. https://i-base.info/htb/31289 This blog discusses …

Simon Collins, HIV i-Base The 15th European AIDS Conference (EACS) is being held this year from 21-24 October 2015. This news page will list links to early reports. However, the unexpected results from the first of these reports on dolutegravir …

Order free copies online of this new mini-guide…

Reports from three conferences. Guidelines. Buying generic PrEP and HCV meds; TTIP; first UK PrEP clinic…

The following links are to recent articles about buying generic medicines online in the UK.  Buying medicines online is perfectly legal in the UK. Neither the UK medicines agency (MHRA) nor HM Customs & Excise have concerns with this, so …

This article is also included in the September/October issue of HTB. https://i-base.info/htb/28949 Simon Collins, HIV i-Base On 30 September 2015, the World Health Organization (WHO) issued a new 78-page guideline document on two important changes to current treatment recommendations. [1, 2] The …

The 5000% increase in price in the US for an off-patent drug by a company with a monopoly license was widely reported yesterday. This was based on a very good article on Monday 21 September in the New York Times. …